Inactive Instrument

News Cellectis S.A. Other OTC

Equities

CMVLF

FR0010425595

Summary

Unlock all the news: Be the first to know and act before the market!

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	06-07	MT
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	06-06	MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	06-05	MT
Cellectis: orphan drug designation in ALL	06-05	CF
Cellectis S A : Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia	06-04	PU
Cellectis Gets Orphan Drug Label From European Commission For Acute Lymphoblastic Leukemia	06-04	MT
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia	06-04	GL
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	06-04	MT
Cellectis S A : Environmental Social & Governance Report - March 2024	06-04	PU
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	05-31	MT
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024	05-29	GL
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	05-29	MT
Transcript : Cellectis S.A., Q1 2024 Earnings Call, May 29, 2024	05-29
Cellectis: operations financed until 2026	05-29	CF
Cellectis S A : Corporate Presentation - May 2024	05-28	PU
Earnings Flash (CLLS) CELLECTIS Posts Q1 Revenue $6.5M	05-28	MT
Cellectis Reports Financial Results for First Quarter 2024	05-28	GL
Cellectis Reports Financial Results for First Quarter 2024	05-28	AQ
Cellectis S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-28	CI
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	05-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cellectis S.A. Other OTC

Equities

CMVLF

FR0010425595

Summary

Filters